Risk analysis of musculoskeletal pain intervention using corticosteroid during COVID-19 pandemic: A cohort study

Mohamad, Azwan Aziz and Mohamed, Nahar Azmi (2023) Risk analysis of musculoskeletal pain intervention using corticosteroid during COVID-19 pandemic: A cohort study. Korean Journal of Pain, 36 (1). pp. 106-112. ISSN 2005-9159, DOI https://doi.org/10.3344/kjp.22249.

Full text not available from this repository.


Background: Most international bodies recommended against musculoskeletal steroid injection during the COVID-19 pandemic, fearing that the immunosuppressive effects of the steroid could worsen COVID-19 infection, thus prolonging the suffering of patients with severe musculoskeletal disease. The authors' aim is to analyze the risk of COVID-19 infection after musculoskeletal injections.Methods: This is a retrospective study of patients who visited a sports medicine clinic and received musculoskeletal steroid injections between January 1, 2020 and February 28, 2021. The collected data was compared with the national COVID-19 registry to identify positive COVID-19 patients. The patients were only considered positive for COVID-19 following corticosteroid injection within 3 months after injection.Results: Out of 502 steroid injections; 79.7% (n = 400) received a single injection in one day, 19.1% (n = 96) received steroid injections at 2 sites in one day, and 1.2% (n = 6) received steroid injections at 3 sites in one day. Using the Fisher & apos;s exact test, there was no statistically significant association of COVID-19 infection between the steroid group and control group (relative risk, 1.44; 95% confidence interval, 0.9-23.1, P = 0.654). Only one patient contracted mild COVID-19 with no post COVID complications.Conclusions: The authors recommend the use of musculoskeletal steroid injections in clinically indicated situation without having increased risk of COVID-19.

Item Type: Article
Funders: None
Uncontrolled Keywords: COVID-19; Injections; Malaysia; Musculoskeletal Pain; Pain Management; Pandemics; Risk Factors; Steroids
Subjects: Q Science > QP Physiology
R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Medicine
Depositing User: Ms Zaharah Ramly
Date Deposited: 27 Nov 2023 08:04
Last Modified: 03 Dec 2023 01:40
URI: http://eprints.um.edu.my/id/eprint/39053

Actions (login required)

View Item View Item